Hemoglobinopathy
1 paper
Trial sponsors
National Heart, Lung, and Blood Institute
3 trialsPhase 3
National Institute of Diabetes and Digestive and Kidney Diseases
1 trialPhase 2100 people
Masonic Cancer Center, University of Minnesota
1 trialPhase 262 people
Memorial Sloan Kettering Cancer Center
1 trialPhase 231 people
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
1 trialPhase 230 people
1 trialPhase 215 people
National Institute of Allergy and Infectious Diseases
1 trialPhase 22 people
1 trialPhase 122 people
Latest
2 in 12 monthsNigerian Medical Journal
Precision Genome Engineering in Human Disease: Expanding Therapeutic Roles of CRISPR Technologies
ReviewInterventions
Mediterranean Journal of Hematology and Infectious Diseases
Aging with Thalassemia and Sickle Cell Disease: A Gerontological Model of Accelerated Multimorbidity and Function-Centered Care Beyond Midlife
ReviewMechanisms
Research and Practice in Thrombosis and Haemostasis
Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias
ReviewInterventions
Journal of Cellular and Molecular Medicine
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4⁺ and CD8⁺ T cells
Trial in peopleInterventions